Global Market Study on Lysosomal Storage Diseases Therapeutics

Oct 2016| PMR049A| Persistence Market Research

Report Highlights

Persistence Market Research examines the global lysosomal storage diseases therapeutics market performance in a new publication. The primary objective of the report is to offer updates and information related to market opportunities in the global lysosomal storage diseases therapeutics market. The report provides key insights pertaining to various segments of the global lysosomal storage diseases therapeutics market and throws light on the key drivers, restraints, and trends likely to impact market growth in the next few years.

The global lysosomal storage diseases therapeutics market report begins by defining various types of therapies available for treatment. This is followed by an overview of market dynamics influencing the global lysosomal storage diseases therapeutics market. Impact analysis of key growth drivers and restraints based on a weighted average model has been included in the global lysosomal storage diseases therapeutics market report after detailed analysis of individual regions to better equip readers with meaningful insights on ongoing developments in the market. The subsequent sections evaluate the present scenario and future growth prospects of the global lysosomal storage diseases therapeutics market on the basis of key segments – by Indication, by Type of Therapy, by End User, and by Region – and provide a detailed analysis of these segments in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and BPS analysis. The global lysosomal storage diseases therapeutics market report provides an overall market outlook and discusses key regional trends contributing to the growth of the global lysosomal storage diseases therapeutics market worldwide and also analyzes the impact of drivers and restraints in each region.

The final section of the global lysosomal storage diseases therapeutics market report includes a comprehensive competitive landscape to provide report audiences with a dashboard view based on categories of providers in the global lysosomal storage diseases therapeutics market product portfolio and key differentiators. Key categories of providers covered in the report are lysosomal storage diseases drug manufacturers. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the global lysosomal storage diseases therapeutics market value chain. The report provides segment-specific vendor insights to help readers identify and evaluate key competitors based on an in-depth assessment of capabilities and success factors. The report also profiles the main providers and discusses their long- and short-term strategies, key offerings, SWOTs, and recent developments in the global lysosomal storage diseases therapeutics market. Shire PLC, Pfizer, Inc., Sanofi, BioMarin Pharmaceutical Inc., Actelion Ltd., Raptor Pharmaceutical Corp., Protalix Biotherapeutics Inc., and Amicus Therapeutics, Inc. are some of the companies featured in the global lysosomal storage diseases therapeutics market report.

Research methodology

The report considers 2015 as the base year and provides data for the forecast period. To ascertain the global lysosomal storage diseases therapeutics market size, Persistence Market Research factors in the revenue generated by manufacturers. The forecast presented in this report assesses the total revenue by value across the global lysosomal storage diseases therapeutics market. In order to offer an accurate forecast, the report begins by sizing up the current market, which forms the basis for how the global lysosomal storage diseases therapeutics market is expected to develop in the future. Given the characteristics of the market, data is triangulated on the basis of three different types of analysis based on supply side, downstream industry demand, and the overall economic envelope.

Further, the report conduct forecasts not only in terms of CAGR, but also analyzes it based on key parameters such as Year-on-Year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the global lysosomal storage diseases therapeutics market. To understand key growth segments in terms of their growth and adoption in the global lysosomal storage diseases therapeutics market, Persistence Market Research has developed an ‘Attractiveness Index’ to help providers identify real market opportunities in the global lysosomal storage diseases therapeutics market.

  • Table 1 : Global Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Type of Therapy, 2015�2026
  • Table 2 : Global Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Indication, 2015�2026
  • Table 3 : Global Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By End User, 2015�2026
  • Table 4 : Global Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Region, 2015�2026
  • Table 5 : North America Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2026
  • Table 6 : North America Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By End User, 2015�2026
  • Table 7 : North America Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Type of Therapy, 2015�2026
  • Table 8 : North America Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Indication, 2015�2026
  • Table 9 : Latin America Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2026
  • Table 10 : Latin America Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By End User, 2015�2026
  • Table 11 : Latin America Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Type of Therapy, 2015�2026
  • Table 12 : Latin America Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Indication, 2015�2026
  • Table 13 : Europe Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2026
  • Table 14 : Europe Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Type of Therapy, 2015�2026
  • Table 15 : Europe Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Indication, 2015�2026
  • Table 16 : Europe Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By End User, 2015�2026
  • Table 17 : APAC Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2026
  • Table 18 : APAC Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Type of Therapy, 2015�2026 �2016 Persistence Market Research, All Rights Reserved 19
  • Table 19 : APAC Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Indication, 2015�2026
  • Table 20 : APAC Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By End User, 2015�2026
  • Table 21 : MEA Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2026
  • Table 22 : MEA Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Type of Therapy, 2015�2026
  • Table 23 : MEA Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By Indication, 2015�2026
  • Table 24 : MEA Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Analysis and Forecast By End User, 2015�2026
  • Figure 1 : Global Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) & Y-o-Y Growth (%), 2015�2026
  • Figure 2 : Global Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 3 : Global Lysosomal Storage Diseases Therapeutics Market Share Analysis (%) By Type of Therapy, 2016 & 2026
  • Figure 4 : Global Lysosomal Storage Diseases Therapeutics Y-o-Y growth (%) By Type of Therapy, 2016�2026
  • Figure 5 : Global Lysosomal Storage Diseases Therapeutics Market Absolute $ opportunity By Enzyme Replacement Therapy Segment, 2016�2026
  • Figure 6 : Global Lysosomal Storage Diseases Therapeutics Market Absolute $ opportunity By Stem Cell Therapy Segment, 2016�2026
  • Figure 7 : Global Lysosomal Storage Diseases Therapeutics Market Absolute $ opportunity By Substrate reduction Therapy Segment, 2016�2026
  • Figure 8 : Global Lysosomal Storage Diseases Therapeutics Market Absolute $ opportunity By Others Segment, 2016�2026
  • Figure 9 : Global Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Type of Therapy, 2016�2026
  • Figure 10 : Global Lysosomal Storage Diseases Therapeutics Market Share Analysis (%) By Indication, 2016 & 2026
  • Figure 11 : Global Lysosomal Storage Diseases Therapeutics Y-o-Y growth (%) By Indication, 2016�2026
  • Figure 12 : Global Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity By Gaucher's Disease Indication Segment, 2016�2026
  • Figure 13 : Global Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity By Fabry Disease Indication Segment, 2016�2026
  • Figure 14 : Global Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity By Pompe�s Syndrome Indication Segment, 2016�2026
  • Figure 15 : Global Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity By Mucopolysaccharidosis Indication Segment, 2016�2026
  • Figure 16 : Global Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity By Others Indication Segment, 2016�2026
  • Figure 17 : Global Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Indication, 2016�2026
  • Figure 18 : Global Lysosomal Storage Diseases Therapeutics Market Share Analysis (%) By End User, 2016 & 2026
  • Figure 19 : Global Lysosomal Storage Diseases Therapeutics Y-o-Y growth (%) By End User, 2016�2026
  • Figure 20 : Global Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity By Hospitals End User Segment, 2016�2026
  • Figure 21 : Global Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity By Clinics End User Segment, 2016�2026
  • Figure 22 : Global Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By End User, 2016�2026
  • Figure 23 : Global Lysosomal Storage Diseases Therapeutics Market Share Analysis (%) By Region, 2016 & 2026
  • Figure 24 : Global Lysosomal Storage Diseases Therapeutics Y-o-Y growth (%) By Region, 2016�2026
  • Figure 25 : North America Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 26 : Latin America Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 27 : Europe Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 28 : Asia Pacific Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 29 : MEA Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 30 : Global Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Region, 2016�2026
  • Figure 31 : North America Lysosomal Storage Diseases Therapeutics Market Share Analysis (%) By Country, 2016 & 2026
  • Figure 32 : North America Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Forecast, 2016�2026
  • Figure 33 : North America Lysosomal Storage Diseases Therapeutics Y-o-Y growth (%) By Country, 2016�2026
  • Figure 34 : The U.S. Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 35 : Canada Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 36 : North America Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Country, 2016�2026
  • Figure 37 : North America Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Type of Therapy, 2016�2026
  • Figure 38 : North America Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Indication, 2016�2026
  • Figure 39 : North America Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By End User, 2016�2026
  • Figure 40 : Latin America Lysosomal Storage Diseases Therapeutics Market Share Analysis (%) By Country, 2016 & 2026
  • Figure 41 : Latin America Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Forecast, 2016�2026
  • Figure 42 : Latin America Lysosomal Storage Diseases Therapeutics Y-o-Y growth (%) By Country, 2016�2026
  • Figure 43 : Brazil Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 44 : Mexico Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 45 : Argentina Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 46 : Rest of Latin America Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 47 : Latin America Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Country, 2016�2026
  • Figure 48 : Latin America Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Type of Therapy, 2016�2026
  • Figure 49 : Latin America Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Indication, 2016�2026
  • Figure 50 : Latin America Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By End User, 2016�2026
  • Figure 51 : Europe Lysosomal Storage Diseases Therapeutics Market Share Analysis (%) By Country, 2016 & 2026
  • Figure 52 : Europe Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Forecast, 2016�2026
  • Figure 53 : Europe Lysosomal Storage Diseases Therapeutics Y-o-Y growth (%) By Country, 2016�2026
  • Figure 54 : Germany Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 55 : France Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 56 : U.K. Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 57 : Spain Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 58 : Italy Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 59 : Russia Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 60 : Rest of Europe Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 61 : Europe Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Country, 2016�2026
  • Figure 62 : Europe Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Type of Therapy, 2016�2026
  • Figure 63 : Europe Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Indication, 2016�2026
  • Figure 64 : Europe Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By End User, 2016�2026
  • Figure 65 : APAC Lysosomal Storage Diseases Therapeutics Market Share Analysis (%) By Country, 2016 & 2026
  • Figure 66 : APAC Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Forecast, 2016�2026
  • Figure 67 : APAC Lysosomal Storage Diseases Therapeutics Y-o-Y growth (%) By Country, 2016�2026
  • Figure 68 : China Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 69 : Japan Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 70 : India Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 71 : Australia & New Zealand Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 72 : Rest of APAC Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 73 : APAC Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Country, 2016�2026
  • Figure 74 : APAC Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Type of Therapy, 2016�2026
  • Figure 75 : APAC Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Indication, 2016�2026
  • Figure 76 : APAC Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By End User, 2016�2026
  • Figure 77 : MEA Lysosomal Storage Diseases Therapeutics Market Share Analysis (%) By Country, 2016 & 2026
  • Figure 78 : MEA Lysosomal Storage Diseases Therapeutics Market Value (US$ Mn) Forecast, 2016�2026
  • Figure 79 : MEA Lysosomal Storage Diseases Therapeutics Y-o-Y growth (%) By Country, 2016�2026
  • Figure 80 : GCC Countries Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 81 : South Africa Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 82 : Rest of MEA Lysosomal Storage Diseases Therapeutics Market Absolute $ Opportunity, 2016�2026
  • Figure 83 : MEA Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Country, 2016�2026
  • Figure 84 : MEA Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Type of Therapy, 2016�2026
  • Figure 85 : MEA Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By Indication, 2016�2026
  • Figure 86 : MEA Lysosomal Storage Diseases Therapeutics Market Attractiveness Analysis By End User, 2016�2026

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report